Nutriband inc. reports revenue up 56% in fiscal 2022 to a record $1.4m

Orlando, fl / accesswire / april 29, 2022 / nutriband inc. (nasdaq:ntrb), a developer of transdermal pharmaceutical products, today announced financial and operational results for the fiscal year ended january 31, 2022. key highlights: generated record revenue of $1.4 million, up 56% over the prior fiscal year completed uplisting to nasdaq capital market in october 2021 and concurrent offering that raised total gross proceeds of approx.
NTRB Ratings Summary
NTRB Quant Ranking